Oncology

Latest News

The findings can help guide ongoing and future clinical trials to help solve remaining challenges in LS-SCLC. | Image credit: Jennifer - stock.adobe

Neoadjuvant Immunotherapy Plus Chemotherapy Shows Promise in LS-SCLC

By Jared Kaltwasser

August 31st 2025

The findings may inform future studies on the therapeutic strategy for patients with small cell lung cancer (SCLC).

PD-1 blockade has previously shown success in a first-line setting in ES-SCLC, and nab-paclitaxel is albumin-bound and solvent-free, which the investigators explained may minimize the toxicity associated with paclitaxel therapy. | Image credit: didesign - stock.adobe.com

Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC

By Jared Kaltwasser

August 29th 2025

For rent sign | Image Credit: David Gales - stock.adobe.com

Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain

By Brooke McCormick

August 28th 2025

Patient with cancer undergoing chemotherapy | Image credit: RFBSIP – stock.adobe.com

Many Patients With Advanced Cancer Report Care Misaligned With Their Goals

By Hayden E. Klein

August 25th 2025

Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap

By Cameron Santoro

August 21st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

Continuing Medical Education

View All

September 1st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

September 1st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

September 3rd 2014

JAMA Study Does Not Find Improved Survival With Double Mastectomy

Survival at 10 years was no better when women had double mastectomies.

September 3rd 2014

ASCO Updates Clinical Guidelines for HER2-Negative Breast Cancer

The guidelines suggest various treatment options available, following consideration of the patient's status and preference.

September 3rd 2014

Halozyme's PEGPH20 Receives Fast-Track Designation

The program is being developed to treat metastatic prostate cancer.

September 3rd 2014

ASCO President Dr Peter P. Yu Defines Value in Cancer Care

Dr Peter P. Yu, MD, Emphasized the importance of value when considering the implications of cancer care.

September 3rd 2014

American Lung Association Applauds CVS: Tobacco Products are Off the Shelf

CVS accelerated its timeline from October to September to stop selling tobacco and related products in its retail stores.

September 2nd 2014

Cabozantinib Fails in Phase 3

The company developing the drug, Excelis, now plans to focus it's attention on the ongoing kidney and liver cancer trials for the drug.

September 2nd 2014

Opioid Abuse and Cancer: The Patient's Perspective

Concerns about addiction and abuse may prevent patients from informing their oncologist about their level of pain.

August 30th 2014

AJMC Series Finds Positive Spin-offs for Cancer Care From New Jersey's Higher Education Overhaul

Status in the States, the series in The American Journal of Managed Care's news publication, Evidence-Based Oncology, took a look at cancer care in New Jersey two years after a high-profile reorganization of the state's higher education system. The overhaul has improved collaboration within research units and with nearby pharmaceutical giants, and a new medical school reports a bumper crop of applicants.

August 29th 2014

MolecularHealth Offers a Reimbursement Calculator

The tool is aimed to provide decision-support to both patients and physicians while considering their reimbursement information.

August 29th 2014

UK's Cancer Drugs Fund Will Improve Access But Evaluate Value

While the 40% funding boost will help patients continue current expensive treatment, or improve access for others, determining "value for money" is high on the NHS agenda.

August 29th 2014

Celgene's Lenalidomide Proves Promising in Ongoing DLBCL Trials

The phase 2 study combined lenalidomide with R-CHOP in newly diagnosed patients.

August 28th 2014

Aetna's Repayment News Points Up Billing Truth: Treatment in Hospitals Costs More

Mary K. Caffrey

This week's news that Aetna would be repaid $8.4 million after uncovering a questionable relationship between three clinics and a hospital has its roots in a well-known managed care reality: If you're treated in a hospital setting, it costs more.

August 28th 2014

Value in Cancer Care: AJMC Publishes ASCO Conference Coverage, Statement from Chief Medical Officer

Evidence-Based Oncology, a news publication of The American Journal of Managed Care, this week published coverage from the 50th Annual Meeting of the American Society of Clinical Oncology. The regular issue of Evidence-Based Oncology, published with the ASCO special issue, features a statement on ASCO's value initiative from Chief Medical Officer Richard L. Schilsky, MD.

August 28th 2014

Organ Arrays For Drug Development-Funded by the ACA

The research, being conducted at UC Berkley, is being funded by the Cures Acceleration Network, which is one of dozens of state and federal agencies established by the health law.

August 28th 2014

IBM's Watson Impacts All Aspects of Discovery Research

Improved cognitive computing by the supercomputer has accelerated the pace of scientific breakthroughs by discovering previously unknown connections in Big Data.

August 27th 2014

Joe Jimenez, Novartis CEO, Doesn't Expect An Early Impact of Biosimilars

Sandoz, the companies generics unit, recently submitted an application with the US FDA for approval of it's biosimilar filgrastim; it's the first-ever biosimilar application with the FDA.

August 27th 2014

Cancer Screening Rates Influenced by Medicaid Reimbursement

The study, published in the journal Cancer, identified a direct correlation between Medicaid payout for office visits and cancer screening in several states.

August 26th 2014

Karen Lewis Discusses the Challenges of the Rapid Expansion of Genetic Testing in Healthcare

Karen Lewis, MS, MM, CGC, medical policy administrator and genetic counselor at Priority Health, said that providers are engaging in genetic testing, but they are doing so in "an uninformed fashion."

August 26th 2014

Pfizer-Merck Immunooncology Collaboration Announced

Following the news that pembrolizumab may be approved earlier than expected, Pfizer and Merck have announced a partnership to evaluate the PD-1 inhibitor in combination with Pfizer's Xalkori.

August 26th 2014

Using the Internet to Recruit Participants in Personalized Trials

The University of Colorado is trying to recruit patients on the internet for a trial to test ponatinib in a rare form of lung cancer.

August 25th 2014

Merck's PD-1 Inhibitor May be Approved Earlier Than Anticipated

Pembrolizumab was expected to be approved by October, but the turnaround might be much earlier.

August 25th 2014

FDA Moves to Regulate Thousands of Diagnostic Tests

Mary K. Caffrey

August 25th 2014

NIH's ALCHEMIST Trial Launched

August 22nd 2014

ASCO's Peter Yu, MD, and Priority Health's Burton VanderLaan, MD, to Give Keynotes at AJMCLive Event

Bringing stakeholders together is the mission of AJMCLive, the meeting series of The American Journal of Managed Care. It's reflected in the two keynote speakers for Patient-Centered Oncology Care on Nov. 14: a leader of physicians, Peter Yu, MD, the current president of ASCO; and a leader among payers, Burton VanderLaan, MD, FACP, medical director of Priority Health.

August 22nd 2014

AJMC Panel: Advances in Multiple Myeloma Therapy Extend Survival for Patients, Raising Cost Concerns

Mary Caffrey Nicole Beagin

August 22nd 2014

Study Points to Lack of Awareness on the BRCA-Ovarian Cancer Relation

75 percent of those at high risk for BRCA mutations have no idea they may have increased chance of ovarian cancer, drawing attention to the importance of genetic counseling.

August 22nd 2014

Beyond the Numbers, Kentucky's Beshear Brings Healthcare Success Stories to State Fair

Mary K. Caffrey

In the twilight of his term of office, Kentucky Gov. Steve Beshear is savoring the political fruits from a leap of faith made 15 months ago, when he spurned his Legislature and opted to expand Medicaid, citing a unique provision in Kentucky regulations. A year after the CMS visit, Beshear and his team are the subject of glowing reports, which describe how a commonwealth with a history of getting things wrong in healthcare has done just about everything right in Obamacare.

August 22nd 2014

3D Printer Generates BiodegradableTargeted Drug Delivery System

An innovative method for using affordable, consumer-grade 3D printers and materials has been developed to fabricate custom medical implants that can contain antibacterial and chemotherapeutic compounds for targeted drug delivery.

August 21st 2014

Illumina To Collaborate With Leading Pharma on a Multigene Diagnostic Panel

The panel, based on next-generation sequencing, will help select the target population - to deliver precision medicine and improve outcomes.

August 21st 2014

AJMC Panel Asks: Does it Pay to Use Pathways?

Nicole Beagin Mary Caffrey

Panel Discussion led by Seema Sonnad,PhD, that saw participation from ASCO's president Peter Paul Yu, MD; Jennifer Malin, MD, PhD, from WellPoint; Chadi Nabhan, MD, FACP, from the University of Chicago; and I.W. Tischler, MD, from Cigna.

...

156 157 158 159 160 161 162 163 164

...

188 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions